A recurring somatic mutation in MYD88 (MYD88 L265P) was identified in 91% of WM patients by paired tumor/normal whole genome sequencing.2▪ By more sensitive allele-specific PCR testing, MYD88 L265P was expressed in 93% to 97% of WM patients. This evidence concerns the gene MYD88 and neoplasm.